A well-integrated data management system was established during the first funding period of this TMRC program. In this request for renewal ofthe program, we plan to expand data collection to include establishment of a Data Surveillance System (DSS) through which ongoing monitoring ofthe population and associated health/disease data can be maintained during and beyond the grant funding period. We will also establish systematic typing procedures through a Molecular Core, maintaining data on parasite loads and HLA type for many subjects in the DSS. As such, maintenance and constant improvement of the data management procedures, and innovative approaches to biostatisticalanalyses, are crucial. Goals ofthe Data and Biostatistics core are: 1. To maintain full in-house data management capacity at BHU in Varanasi and its associated field site in Muzaffarpur, Bihar State. This includes maintenance and quality control of an electronic data management system operating at BHU. 2. To maintain a record of specimens through the data management system, linking specimens to the database and to HLA and qPCR status obtained through Core D (molecular typing). The use of specimens and distribution between investigators on the four projects will be catalogued through the specimen control system, managed by the director of specimen control. 3. To provide support and quality control mechanisms for each of the two cores and four research projects. This will include the development of Standard Operating Procedures (SOPs) for clinical studies, specimen collection, specimen handling, data management and clinical monitoring procedures. 4. To provide expertise and support in biostatistics, allowing ongoing analysis of programs and feedback to regarding SOPs and data management. The system is designed to allow BHU to carry out FDA-compliant clinical trials or vaccine studies in the future.

Public Health Relevance

A well maintained and improved Data Management System is essential to meet overall objectives ofthe projects and cores. Data Management and Biostatistics Core will record and manage the data collected through DSS and will help other projects and cores to get their sample population and data.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center (P50)
Project #
4P50AI074321-07
Application #
8473762
Study Section
Special Emphasis Panel (ZAI1-AWA-M)
Project Start
2013-08-01
Project End
2017-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
7
Fiscal Year
2013
Total Cost
$46,713
Indirect Cost
$3,460
Name
Banaras Hindu University
Department
Type
DUNS #
650330558
City
Varanasi
State
Country
India
Zip Code
22100-5
Sundar, Shyam; Singh, Bhawana (2018) Understanding Leishmania parasites through proteomics and implications for the clinic. Expert Rev Proteomics 15:371-390
Sundar, Shyam; Agarwal, Dipti (2018) Visceral Leishmaniasis-Optimum Treatment Options in Children. Pediatr Infect Dis J 37:492-494
Singh, Neetu; Sundar, Shyam (2018) Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis. PLoS One 13:e0199817
Singh, Neetu; Kumar, Rajiv; Chauhan, Shashi Bhushan et al. (2018) Peripheral Blood Monocytes With an Antiinflammatory Phenotype Display Limited Phagocytosis and Oxidative Burst in Patients With Visceral Leishmaniasis. J Infect Dis 218:1130-1141
Singh, Toolika; Fakiola, Michaela; Oommen, Joyce et al. (2018) Epitope-Binding Characteristics for Risk versus Protective DRB1 Alleles for Visceral Leishmaniasis. J Immunol 200:2727-2737
Sundar, Shyam; Singh, Anup (2018) Chemotherapeutics of visceral leishmaniasis: present and future developments. Parasitology 145:481-489
Sundar, Shyam; Singh, Bhawana (2018) Emerging therapeutic targets for treatment of leishmaniasis. Expert Opin Ther Targets 22:467-486
Kelly, Patrick H; Bahr, Sarah M; Serafim, Tiago D et al. (2017) The Gut Microbiome of the Vector Lutzomyia longipalpis Is Essential for Survival of Leishmania infantum. MBio 8:
Sharma, Smriti; Srivastva, Shweta; Davis, Richard E et al. (2017) The Phenotype of Circulating Neutrophils during Visceral Leishmaniasis. Am J Trop Med Hyg 97:767-770
Kansal, S; Chakravarty, J; Kumar, A et al. (2017) Risk Factors associated with defaulting from visceral leishmaniasis treatment: analysis under routine programme conditions in Bihar, India. Trop Med Int Health 22:1037-1042

Showing the most recent 10 out of 90 publications